Drug development in the blink of an eye
Monday, August 8, 2011 - 20:30
in Health & Medicine
The development of drugs for brain-related conditions is not an efficient process. A key reason for this is a lack of preclinical tests that accurately predict drug efficacy and detect unwanted side effects. But now, researchers have developed a new preclinical approach that they hope can be used alongside current strategies to guide more efficient drug development for brain-related conditions.